This makes all usage experimental and potentially unsafe
Maintaining this calorie deficit encourages lipolysis, the process that releases stored fat for energy, and shifts the body's fuel use toward fatty acids
[16] [17] Urinalysis and urine culture are indicated, with appropriate antibiotic therapy if infection is confirmed
Heres what I conclude: GLP-1 microdosing and off-label use occupy an uncomfortable gray zone - strong mechanistic rationale, consistent observational patterns, but limited controlled human data
The current Biofast page also positions the product for medical professionals, aesthetic clinics, and sports medicine specialists
Suggested Use: Take one packet 1-2 times a day before meals, or as directed by your healthcare professional